The Proper Diet and Regular Physical Activity Slow Down the Development of Parkinson Disease
- PMID: 34631210
- PMCID: PMC8460298
- DOI: 10.14336/AD.2021.0123
The Proper Diet and Regular Physical Activity Slow Down the Development of Parkinson Disease
Abstract
From year to year, we know more about neurodegeneration and Parkinson's disease (PD). A positive influence of various types of physical activity is more often described in the context of neuroprotection and prevention as well as the form of rehabilitation in Parkinson's patients. Moreover, when we look at supplementation, clinical nutrition and dietetics, we will see that balancing consumed products and supplementing the vitamins or minerals is necessary. Considering the biochemical pathways in skeletal muscle, we may see that many researchers desire to identify molecular mediators that have an impact through exercise and balanced diet on human health or development of the neurodegenerative disease. Therefore, it is mandatory to study the potential mechanism(s) related to diet and factors resulted from physical activity as molecular mediators, which play a therapeutic role in PD. This review summarizes the available literature on mechanisms and specific pathways involved in diet-exercise relationship and discusses how therapy, including appropriate exercises and diet that influence molecular mediators, may significantly slow down the progress of neurodegenerative processes. We suggest that a proper diet combined with physical activity will be a good solution for psycho-muscle BALANCE not only in PD but also in other neurodegenerative diseases.
Keywords: Parkinson’s disease; diet; neuroinflammation; neuroprotection; physical exercise.
copyright: © 2021 Chromiec et al.
Conflict of interest statement
Conflicts of Interest The authors declare no conflict of interest.
Figures


Similar articles
-
Aerobic Exercise and Healthy Nutrition as Neuroprotective Agents for Brain Health in Patients with Parkinson's Disease: A Critical Review of the Literature.Antioxidants (Basel). 2020 May 5;9(5):380. doi: 10.3390/antiox9050380. Antioxidants (Basel). 2020. PMID: 32380715 Free PMC article. Review.
-
The role of trophic factors and inflammatory processes in physical activity-induced neuroprotection in Parkinson's disease.Postepy Hig Med Dosw (Online). 2017 Jan 4;71(1):713-726. doi: 10.5604/01.3001.0010.3850. Postepy Hig Med Dosw (Online). 2017. PMID: 28894046 Review.
-
Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: A critical perspective review.Pharmacol Res. 2020 Nov;161:105065. doi: 10.1016/j.phrs.2020.105065. Epub 2020 Jul 8. Pharmacol Res. 2020. PMID: 32652199
-
Mitochondrial biogenesis: pharmacological approaches.Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118. Curr Pharm Des. 2014. PMID: 24606795
-
Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.Hum Gene Ther. 2001 Aug 10;12(12):1589-91. Hum Gene Ther. 2001. PMID: 11529246 Clinical Trial.
Cited by
-
Mobile health technology, exercise adherence and optimal nutrition post rehabilitation among people with Parkinson's Disease (mHEXANUT) - a randomized controlled trial protocol.BMC Neurol. 2023 Mar 2;23(1):93. doi: 10.1186/s12883-023-03134-5. BMC Neurol. 2023. PMID: 36864377 Free PMC article.
-
Effect of 12-Week BMI-Based Vitamin D3 Supplementation in Parkinson's Disease with Deep Brain Stimulation on Physical Performance, Inflammation, and Vitamin D Metabolites.Int J Mol Sci. 2023 Jun 15;24(12):10200. doi: 10.3390/ijms241210200. Int J Mol Sci. 2023. PMID: 37373347 Free PMC article. Clinical Trial.
-
Selecting the Best Animal Model of Parkinson's Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies.Curr Neuropharmacol. 2023;21(5):1241-1272. doi: 10.2174/1570159X21666230216101659. Curr Neuropharmacol. 2023. PMID: 36797611 Free PMC article.
-
Reduced composite dietary antioxidant index increases the risk of Parkinson's disease and all-cause mortality in Parkinson's disease patients: evidence from the NHANES database.Front Aging Neurosci. 2025 Apr 17;17:1510654. doi: 10.3389/fnagi.2025.1510654. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40330594 Free PMC article.
-
Endoplasmic Reticulum Proteins Impact Penetrance in a Pink1-Mutant Drosophila Model.Int J Mol Sci. 2025 Jan 24;26(3):979. doi: 10.3390/ijms26030979. Int J Mol Sci. 2025. PMID: 39940747 Free PMC article.
References
-
- Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G (2005). Burden of illness in Parkinson’s disease. Mov Disord, 20:1449-1454. - PubMed
-
- Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA (2010). Predictors of future falls in Parkinson disease. Neurology, 75:116-124. - PubMed
-
- Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM (2003). Gait dynamics in Parkinson’s disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci, 212:47-53. - PubMed
-
- Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, et al.. (2009). Clinical features in early Parkinson disease and survival. Arch Neurol, 66:1353-1358. - PubMed
Publication types
LinkOut - more resources
Full Text Sources